Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration

Beth M. McMahon, Dennis Mays, James Lipsky, Jennifer A. Stewart, Abdul Fauq, Elliott Richelson

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Peptide nucleic acids (PNAs) are DNA analogs that hybridize to complementary nucleic sequences with high affinity and stability. In our previous work, we showed that a PNA complementary to a 12-base pair (bp) sequence of the coding region of the rat neurotensin receptor (rNTR1) mRNA is effective in significantly blocking a rat's central responses to neurotensin (NT), even when the PNA is injected intraperitoneally (i.p.). Using a novel gel shift detection assay to detect PNA, we have now used this same PNA sequence to derive its pharmacokinetic variables and its tissue distribution in the rat. The PNA has a distribution half-life of 3 ± 3 minutes and an elimination half-life of 17 ± 3 minutes. The total plasma clearance and volume of distribution of this PNA were 3.4 ± 0.9 ml/min and 60 ± 30 ml/kg. Two hours after dosing, the PNA was found at detectable but low levels in all organs examined-in order of decreasing concentration: kidney, liver, heart, brain, and spleen. Approximately 90% of the PNA dose was recovered as unchanged parent compound in the urine 24 hours after administration.

Original languageEnglish (US)
Pages (from-to)65-70
Number of pages6
JournalAntisense and Nucleic Acid Drug Development
Volume12
Issue number2
StatePublished - 2002

Fingerprint

Peptide Nucleic Acids
Pharmacokinetics
Tissue Distribution
Intravenous Administration
Tissue
Rats
Half-Life
Nucleic acid sequences
Neurotensin Receptors
Neurotensin
Plasma Volume
Base Pairing
Liver
Assays
Brain
Spleen
Gels
Urine
Kidney
Plasmas

ASJC Scopus subject areas

  • Genetics
  • Pharmacology

Cite this

McMahon, B. M., Mays, D., Lipsky, J., Stewart, J. A., Fauq, A., & Richelson, E. (2002). Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration. Antisense and Nucleic Acid Drug Development, 12(2), 65-70.

Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration. / McMahon, Beth M.; Mays, Dennis; Lipsky, James; Stewart, Jennifer A.; Fauq, Abdul; Richelson, Elliott.

In: Antisense and Nucleic Acid Drug Development, Vol. 12, No. 2, 2002, p. 65-70.

Research output: Contribution to journalArticle

McMahon, BM, Mays, D, Lipsky, J, Stewart, JA, Fauq, A & Richelson, E 2002, 'Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration', Antisense and Nucleic Acid Drug Development, vol. 12, no. 2, pp. 65-70.
McMahon, Beth M. ; Mays, Dennis ; Lipsky, James ; Stewart, Jennifer A. ; Fauq, Abdul ; Richelson, Elliott. / Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration. In: Antisense and Nucleic Acid Drug Development. 2002 ; Vol. 12, No. 2. pp. 65-70.
@article{e406d6379c064e9f92af15f93009a7bc,
title = "Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration",
abstract = "Peptide nucleic acids (PNAs) are DNA analogs that hybridize to complementary nucleic sequences with high affinity and stability. In our previous work, we showed that a PNA complementary to a 12-base pair (bp) sequence of the coding region of the rat neurotensin receptor (rNTR1) mRNA is effective in significantly blocking a rat's central responses to neurotensin (NT), even when the PNA is injected intraperitoneally (i.p.). Using a novel gel shift detection assay to detect PNA, we have now used this same PNA sequence to derive its pharmacokinetic variables and its tissue distribution in the rat. The PNA has a distribution half-life of 3 ± 3 minutes and an elimination half-life of 17 ± 3 minutes. The total plasma clearance and volume of distribution of this PNA were 3.4 ± 0.9 ml/min and 60 ± 30 ml/kg. Two hours after dosing, the PNA was found at detectable but low levels in all organs examined-in order of decreasing concentration: kidney, liver, heart, brain, and spleen. Approximately 90{\%} of the PNA dose was recovered as unchanged parent compound in the urine 24 hours after administration.",
author = "McMahon, {Beth M.} and Dennis Mays and James Lipsky and Stewart, {Jennifer A.} and Abdul Fauq and Elliott Richelson",
year = "2002",
language = "English (US)",
volume = "12",
pages = "65--70",
journal = "Nucleic Acid Therapeutics",
issn = "2159-3337",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration

AU - McMahon, Beth M.

AU - Mays, Dennis

AU - Lipsky, James

AU - Stewart, Jennifer A.

AU - Fauq, Abdul

AU - Richelson, Elliott

PY - 2002

Y1 - 2002

N2 - Peptide nucleic acids (PNAs) are DNA analogs that hybridize to complementary nucleic sequences with high affinity and stability. In our previous work, we showed that a PNA complementary to a 12-base pair (bp) sequence of the coding region of the rat neurotensin receptor (rNTR1) mRNA is effective in significantly blocking a rat's central responses to neurotensin (NT), even when the PNA is injected intraperitoneally (i.p.). Using a novel gel shift detection assay to detect PNA, we have now used this same PNA sequence to derive its pharmacokinetic variables and its tissue distribution in the rat. The PNA has a distribution half-life of 3 ± 3 minutes and an elimination half-life of 17 ± 3 minutes. The total plasma clearance and volume of distribution of this PNA were 3.4 ± 0.9 ml/min and 60 ± 30 ml/kg. Two hours after dosing, the PNA was found at detectable but low levels in all organs examined-in order of decreasing concentration: kidney, liver, heart, brain, and spleen. Approximately 90% of the PNA dose was recovered as unchanged parent compound in the urine 24 hours after administration.

AB - Peptide nucleic acids (PNAs) are DNA analogs that hybridize to complementary nucleic sequences with high affinity and stability. In our previous work, we showed that a PNA complementary to a 12-base pair (bp) sequence of the coding region of the rat neurotensin receptor (rNTR1) mRNA is effective in significantly blocking a rat's central responses to neurotensin (NT), even when the PNA is injected intraperitoneally (i.p.). Using a novel gel shift detection assay to detect PNA, we have now used this same PNA sequence to derive its pharmacokinetic variables and its tissue distribution in the rat. The PNA has a distribution half-life of 3 ± 3 minutes and an elimination half-life of 17 ± 3 minutes. The total plasma clearance and volume of distribution of this PNA were 3.4 ± 0.9 ml/min and 60 ± 30 ml/kg. Two hours after dosing, the PNA was found at detectable but low levels in all organs examined-in order of decreasing concentration: kidney, liver, heart, brain, and spleen. Approximately 90% of the PNA dose was recovered as unchanged parent compound in the urine 24 hours after administration.

UR - http://www.scopus.com/inward/record.url?scp=0035989848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035989848&partnerID=8YFLogxK

M3 - Article

C2 - 12074366

AN - SCOPUS:0035989848

VL - 12

SP - 65

EP - 70

JO - Nucleic Acid Therapeutics

JF - Nucleic Acid Therapeutics

SN - 2159-3337

IS - 2

ER -